NCT00304070 · OUTCOME

Molecular Alterations and Embryonal Markers in Children With ACT - A43 del33bp Mutation of (Beta)-Catenin.

Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor · Source last updated 2024-02-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: COUNT_OF_PARTICIPANTS
Unit: Participants
Interval / dispersion: Not reported
Time frame: Patients who had surgery at time of enrollment.

What was measured

The number of eligible patients who have A43 del33bp mutation of (beta)-catenin.

Analysis population: Fifty-eight eligible patients had material examined for the presence of (beta)-catenin mutations.

Groups in this outcome

All Patients

Regardless of Arm/Group assignment, the number of eligible patients who had surgery at study enrollment and have A43 del33bp mutation of (beta)-catenins.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
All Patients	58

Reported measurements

children with ACT - wild type (beta)-catenin

Values in Participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
All Patients	51	Not reported	Not reported	Not reported	Not reported

A43 del33bp mutation of (beta)-catenin

Values in Participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
All Patients	1	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
51
title
children with ACT - wild type (beta)-catenin
categories
measurements
group Id
OG000
value
1
title
A43 del33bp mutation of (beta)-catenin

denoms

counts
group Id
OG000
value
58
units
Participants

description

The number of eligible patients who have A43 del33bp mutation of (beta)-catenin.

groups

description
Regardless of Arm/Group assignment, the number of eligible patients who had surgery at study enrollment and have A43 del33bp mutation of (beta)-catenins.
id
OG000
title
All Patients

param Type

COUNT_OF_PARTICIPANTS

population Description

Fifty-eight eligible patients had material examined for the presence of (beta)-catenin mutations.

reporting Status

POSTED

time Frame

Patients who had surgery at time of enrollment.

title

Molecular Alterations and Embryonal Markers in Children With ACT - A43 del33bp Mutation of (Beta)-Catenin.

type

SECONDARY

unit Of Measure

Participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice